Grants>Pancreas

Lustgarten Foundation Research Funding Opportunities

Concept Due Date:  May 24, 2013

Full Applications Due: August 9, 2013

Funding to begin January 2014

The Lustgarten Foundation (LF) is the nation’s largest private funder of pancreatic cancer research. Our mission is to advance scientific and medical research related to the diagnosis, treatment, cure and prevention of pancreatic cancer. Thanks to the support of Cablevision, 100% of all our donations go directly to research, which has enabled us to commit $65 Million to outstanding research projects to date.

For the 2013 Grant application cycle, The Foundation’s Scientific Review Board has identified a number of research areas for which proposals are now being solicited (below).

Research Topics

Clinical/Translational RFA's

Early Detection and Risk Assessment in Pancreas Cancer

New Drug Delivery Approaches in Pancreas Cancer

Novel Imaging Technologies in Pancreas Cancer

Novel Therapeutic Agents in Pancreas Cancer

Correlative Studies Awards Program

Preclinical RFA's

Novel Agents for Pancreas Cancer

Clinical and Molecular Markers of Metastic Burden

Basic RFA's

Immune Surveillance and Modulation

Early Stage Target Validation for Pancreas Cancer

Impact of Chromatin Alteration in Pancreas Cancer

New Models of PDAC

Requests for Applications: Biomarkers of Pancreatic Beta Cell Stress and Health

JDRF, the world’s leading non-profit organization with the mission to cure type 1 diabetes (T1D), invites applications from research investigators having interest and expertise to support the discovery and advancement of biomarkers of pancreatic beta cell stress and health correlating with early beta-cell loss.

The purpose of this call for Letters of Intent is to invite proposals to support and advance the discovery, development, and/or validation of biomarkers of pancreatic beta cell stress and dysfunction. Studies based on use or validation with human beta cells/islets and clinical samples or tissues will be of special interest.

MECHANISM

Applications in response to this announcement can be submitted under one of the following funding mechanisms:
Pilot & Feasibility Grants (P&Fs): up to $110,000 (including 10% indirect costs) for one year only.

Strategic Research Agreements (SRAs): Up to $250,000 USD per year including 10% indirect costs
for up to 3 years may be requested. The level of funding will vary depending on the scope and overall objectives of the proposal. Under the terms of the grant award, written quarterly (~2-3 pages) reports will be required from the funded investigator as a basis for continued support.

LETTER OF INTENT

Prospective applicants should submit a letter of intent on -line via the proposalCENTRAL website (https://proposalcentral.altum.com/default.asp).

The LOI template provided on the proposalCENTRAL Web site must be used to complete the application. Applicants will be notified approximately eight weeks after the LOI deadline date if they have been approved to submit a full application.

Letter of Intent Deadline: June 17, 2013.